These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28583972)

  • 1. A Black Alzheimer's Patient Wants To Be Part Of The Cure.
    Gray K
    Health Aff (Millwood); 2017 Jun; 36(6):1129-1132. PubMed ID: 28583972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease in African Americans: risk factors and challenges for the future.
    Barnes LL; Bennett DA
    Health Aff (Millwood); 2014 Apr; 33(4):580-6. PubMed ID: 24711318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018.
    Denny A; Streitz M; Stock K; Balls-Berry JE; Barnes LL; Byrd GS; Croff R; Gao S; Glover CM; Hendrie HC; Hu WT; Manly JJ; Moulder KL; Stark S; Thomas SB; Whitmer R; Wong R; Morris JC; Lingler JH
    Alzheimers Dement; 2020 Dec; 16(12):1734-1744. PubMed ID: 33034414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of black elderly for clinical research studies of dementia: the CERAD experience.
    Ballard EL; Nash F; Raiford K; Harrell LE
    Gerontologist; 1993 Aug; 33(4):561-5. PubMed ID: 8375688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease.
    Misiura MB; Butts B; Hammerschlag B; Munkombwe C; Bird A; Fyffe M; Hemphill A; Dotson VM; Wharton W
    Neurotherapeutics; 2023 Jul; 20(4):1019-1036. PubMed ID: 37490246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interdisciplinary outreach model of African American recruitment for Alzheimer's disease research.
    Williams MM; Meisel MM; Williams J; Morris JC
    Gerontologist; 2011 Jun; 51 Suppl 1(Suppl 1):S134-41. PubMed ID: 21173436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proactive Recruitment of Older African-Americans for Alzheimer's Research with Brain Donation: a Cohort Case Study of Success.
    Gamboa CJ; Julion WA
    J Racial Ethn Health Disparities; 2021 Apr; 8(2):463-474. PubMed ID: 32588397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. African American participation in Alzheimer's disease research that includes brain donation.
    Darnell KR; McGuire C; Danner DD
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):469-76. PubMed ID: 22009227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost.
    Underwood E
    Science; 2015 Jul; 349(6247):464. PubMed ID: 26228122
    [No Abstract]   [Full Text] [Related]  

  • 10. Knowledge and Attitudes in Alzheimer's Disease in a Cohort of Older African Americans and Caucasians.
    Howell JC; Soyinka O; Parker M; Jarrett TL; Roberts DL; Dorbin CD; Hu WT
    Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):361-7. PubMed ID: 26646115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promise of new Alzheimer's drug is dashed after lack of evidence.
    Hawkes N
    BMJ; 2016 Nov; 355():i6362. PubMed ID: 27884817
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's drug donanemab: what promising trial means for treatments.
    Reardon S
    Nature; 2023 May; 617(7960):232-233. PubMed ID: 37142723
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Establishing a Trial Ready Cohort to Accelerate Alzheimer's Clinical Trial Enrollment and Treatments.
    Meyers EA; Carrillo MC
    J Prev Alzheimers Dis; 2020; 7(4):202-203. PubMed ID: 32920618
    [No Abstract]   [Full Text] [Related]  

  • 15. Aducanumab for Alzheimer's disease?
    Walsh S; Merrick R; Milne R; Brayne C
    BMJ; 2021 Jul; 374():n1682. PubMed ID: 34226181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological test performance in African-American and white patients with Alzheimer's disease.
    Welsh KA; Fillenbaum G; Wilkinson W; Heyman A; Mohs RC; Stern Y; Harrell L; Edland SD; Beekly D
    Neurology; 1995 Dec; 45(12):2207-11. PubMed ID: 8848195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Hope for Alzheimer's Disease.
    Vellas B; Aisen P
    J Prev Alzheimers Dis; 2021; 8(3):238-239. PubMed ID: 34101778
    [No Abstract]   [Full Text] [Related]  

  • 18. Mortality from Alzheimer's disease in the United States: data for 2000 and 2010.
    Tejada-Vera B
    NCHS Data Brief; 2013 Mar; (116):1-8. PubMed ID: 23742787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US FDA defends approval of Alzheimer's disease drug.
    Jaffe S
    Lancet; 2021 Jul; 398(10294):12. PubMed ID: 34217382
    [No Abstract]   [Full Text] [Related]  

  • 20. A contentious FDA ruling for Alzheimer's disease.
    The Lancet Neurology
    Lancet Neurol; 2021 Aug; 20(8):585. PubMed ID: 34237273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.